CG Oncology, Inc. (CGON) - Uzoq muddatli qarzning kapitalga nisbati
Quyida aks etgan narxlar tendentsiyasi CG Oncology, Inc. (CGON) kompaniyasining hujayra madaniyatini tahlil qilish uchun raqamli algoritmlarni joriy etayotgani haqidagi ma'lumotlarni to'ldiradi. Joriy ko'rsatkich 0.01 darajasida turibdi. Biznes istiqbollari cretostimogene preparatining bozorga chiqarilishi, FDA tasdig'i va xarajatlarni boshqarishga bog'liq. Shu bilan birga, CG Oncology, Inc. (CGON) tibbiy yutuqlarga erishish uchun premium infratuzilmani yaratish va daromadli shartnomalar taklif qilish orqali yetakchi olimlarni jalb qilmoqda.
%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_CGON_-_CG-Oncology-Inc._-_Long-Term-Debt-to-Equity "cgoncology.com (CGON): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi 21.02.2024dan 01.11.2026gacha | 👁️GURU.Markets👁️")
CG Oncology, Inc. kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
- kompaniyaning balans qiymati tafsilotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Qarzning kapitalga nisbati CG Oncology, Inc.|CGON - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati cgoncology.com|CGON - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati CG Oncology, Inc.|CGON - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari CG Oncology|Tezkor likvidlik koeffitsiyenti cgoncology.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
Kompaniyaning umumiy tahlili:CG Oncology Inc - CGON
Ushbu ko'rsatkich bir yildan ortiq muddatli majburiyatlarning kapitalga nisbatini baholaydi va kompaniyaning uzoq muddatli rivojlanish uchun qarz moliyalashtirishga qanchalik bog'liqligini aniqlaydi. GURU.Markets orqali uzoq muddatli qarzning kapitalga nisbatidagi dinamikasini tahlil qilish orqali investor CG Oncology, Inc. (CGON) kompaniyasining premium saraton immunoterapiyasi segmentiga kengayish uchun moliyaviy zaxirasini ko'rishi mumkin, bu yerda patent monopoliyasi yuqori marja va qarzlarining oson xizmat ko'rsatilishini ta'minlaydi.
Muhim raqobatchilar
Uzoq muddatli qarzning o'z kapitaliga nisbati BeiGene Ltd. (ONC)|Uzoq muddatli qarzning kapitalga nisbati HALO|Uzoq muddatli qarzning kapitalga nisbati Revolution Medicines Corp (RVMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Ascentage Pharma Group AAPG|URGN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Bicara Therapeutics - Uzoq muddatli qarzning kapitalga nisbati|Personalis Inc (PSNL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ERAS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Delcath Corp (DCTH)|Uzoq muddatli qarzning o'z kapitaliga nisbati Y-mAbs Therapeutics|AURA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CADL (Candel Therapeutics)|ARAY (Accuray Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati SLS (SELLAS Life Sciences Group)|ACTU - Uzoq muddatli qarzning o'z kapitaliga nisbati|CTOR: Uzoq muddatli qarzning o'z kapitaliga nisbati|HURA - Uzoq muddatli qarzning kapitalga nisbati|Protara Therapeutics, Inc. (TARA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Fate Therapeutics Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati TScan TCRX|Uzoq muddatli qarzning kapitalga nisbati CSBR|Uzoq muddatli qarzning o'z kapitaliga nisbati xbiotech.com XBIT|Uzoq muddatli qarzning kapitalga nisbati CVM (CEL-SCI)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati OS Therapies Inc.|RADX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ARTV (Artiva Biotherapeutics, Inc.)|adlainortye.com (ANL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati verupharma.com (VERU)|Uzoq muddatli qarzning o'z kapitaliga nisbati Tempest Therapeutics, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi XLO (Xilio)|Uzoq muddatli qarzning kapitalga nisbati RENB|Uzoq muddatli qarzning o'z kapitaliga nisbati muraloncology.com MURA|Uzoq muddatli qarzning o'z kapitaliga nisbati Kairos Pharma KAPA|OnKure Therapeutics, Inc. (OKUR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|GDTC - Uzoq muddatli qarzning o'z kapitaliga nisbati|CRIS: Uzoq muddatli qarzning o'z kapitaliga nisbati|apollomicsinc.com (APLM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Tharimmune Corporation (THAR)|ADVB (Advanced Biomed Inc.) - Uzoq muddatli qarzning kapitalga nisbati|GNPX - Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CLDI (Calidi Biotherapeutics)|SBFM - Uzoq muddatli majburiyatlarning kapitalga nisbati|Xenetic Biosciences, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti SLRX|Purple Biotech - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati American Oncology Network AONC|BeiGene (BGNE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi CKPT|ELEV (Elevation Oncology, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati iCAD Corp (ICAD)|Uzoq muddatli qarzning o'z kapitaliga nisbati IKNA (Ikena Oncology, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati notablelabs.com|Uzoq muddatli qarzning kapitalga nisbati VIRX (Viracta Therapeutics, Inc.)|MOR - Uzoq muddatli qarzning o'z kapitaliga nisbati|NAYA Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Ascentage (AAPGV)